阿尔茨海默病的干细胞治疗:目前的状况和前景
Chu-Min Ou1, Wei-Wei Xue1,2, Dong Liu1
1Guangdong Celconta Biotechnology Co., Ltd., Dongguan, Guangdong, China.
Frontiers in neuroscience
|December 6, 2024
概括
阿尔茨海默病 (AD) 针对团和粉样斑块的治疗方法有限. 干细胞治疗为修复受损的大脑细胞和治疗这种神经退行性疾病提供了一个有希望的替代方案.
科学领域:
- 神经科学是一个神经科学.
- 再生医学是一种再生医学.
- 生物技术是生物技术.
背景情况:
- 阿尔茨海默病 (AD) 是全球健康危机的主要原因,其特点是认知障碍和神经元损失.
- 目前针对陶蛋白纠和β-粉样蛋白 (Aβ) 斑块的AD治疗方法具有有限的疗效,主要是在没有细胞修复的情况下控制症状.
- 基于干细胞的疗法,由于其再生潜力,为AD治疗提供了一种新的策略.
研究的目的:
- 审查阿尔茨海默病治疗的临床前和临床进展.
- 探索干细胞疗法的潜力,作为AD的替代方法.
- 总结针对蛋白纠和Aβ斑块的研究,以及在AD中的干细胞应用.
主要方法:
- 对阿尔茨海默病的临床前和临床研究的审查.
- 对蛋白和Aβ斑块向治疗策略的分析.
- 检查在AD治疗研究中使用的四种类型的干细胞.
主要成果:
- 目前针对AD的治疗方法在修复神经元损伤方面表现出有限的成功.
- 干细胞具有自我更新和分化能力,使其适合基于细胞的疗法.
- 多项研究正在调查阿尔茨海默病的干细胞应用.
结论:
- 干细胞疗法在治疗阿尔茨海默病方面具有显著的前景,因为它有可能修复受损的神经细胞.
- 需要进一步的研究和临床试验,才能充分确定AD的干细胞治疗的疗效和安全性.
- 向状结和Aβ斑块等病理特征仍然是重点关注的重点,干细胞提供了补充或替代方法.
相关概念视频
Alzheimer's Disease: Treatment
163
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
163
Alzheimer's Disease: Overview
447
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
447
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Stem Cell Culture
5.1K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.1K
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K


